AU2002221702A1 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- AU2002221702A1 AU2002221702A1 AU2002221702A AU2170202A AU2002221702A1 AU 2002221702 A1 AU2002221702 A1 AU 2002221702A1 AU 2002221702 A AU2002221702 A AU 2002221702A AU 2170202 A AU2170202 A AU 2170202A AU 2002221702 A1 AU2002221702 A1 AU 2002221702A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- mum
- median
- particles
- clavulanic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D503/10—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D503/12—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6
- C07D503/14—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, other than a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, attached in position 3
- C07D503/16—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical
- C07D503/18—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Clavulanic acid, in which the median of the particles is from 8 mum to 35 mum and their use in pharmaceutical compositions.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT1806/2000 | 2000-10-20 | ||
AT18062000 | 2000-10-20 | ||
PCT/EP2001/012076 WO2002032906A1 (en) | 2000-10-20 | 2001-10-18 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002221702A1 true AU2002221702A1 (en) | 2002-04-29 |
Family
ID=3689001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002221702A Abandoned AU2002221702A1 (en) | 2000-10-20 | 2001-10-18 | Pharmaceutical compositions |
Country Status (13)
Country | Link |
---|---|
US (1) | US20040043981A1 (en) |
EP (1) | EP1328528B1 (en) |
JP (2) | JP2004511561A (en) |
KR (1) | KR20030069995A (en) |
CN (1) | CN1267437C (en) |
AT (1) | ATE286057T1 (en) |
AU (1) | AU2002221702A1 (en) |
CA (1) | CA2424462C (en) |
DE (1) | DE60108154T2 (en) |
ES (1) | ES2234919T3 (en) |
MX (1) | MXPA03003312A (en) |
PL (1) | PL360254A1 (en) |
WO (1) | WO2002032906A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7295509B2 (en) | 2000-09-13 | 2007-11-13 | Qualcomm, Incorporated | Signaling method in an OFDM multiple access system |
US9130810B2 (en) | 2000-09-13 | 2015-09-08 | Qualcomm Incorporated | OFDM communications methods and apparatus |
US9246560B2 (en) | 2005-03-10 | 2016-01-26 | Qualcomm Incorporated | Systems and methods for beamforming and rate control in a multi-input multi-output communication systems |
US9154211B2 (en) | 2005-03-11 | 2015-10-06 | Qualcomm Incorporated | Systems and methods for beamforming feedback in multi antenna communication systems |
US8446892B2 (en) | 2005-03-16 | 2013-05-21 | Qualcomm Incorporated | Channel structures for a quasi-orthogonal multiple-access communication system |
US9520972B2 (en) | 2005-03-17 | 2016-12-13 | Qualcomm Incorporated | Pilot signal transmission for an orthogonal frequency division wireless communication system |
US9143305B2 (en) | 2005-03-17 | 2015-09-22 | Qualcomm Incorporated | Pilot signal transmission for an orthogonal frequency division wireless communication system |
US9184870B2 (en) | 2005-04-01 | 2015-11-10 | Qualcomm Incorporated | Systems and methods for control channel signaling |
US9036538B2 (en) | 2005-04-19 | 2015-05-19 | Qualcomm Incorporated | Frequency hopping design for single carrier FDMA systems |
US9408220B2 (en) | 2005-04-19 | 2016-08-02 | Qualcomm Incorporated | Channel quality reporting for adaptive sectorization |
US8879511B2 (en) | 2005-10-27 | 2014-11-04 | Qualcomm Incorporated | Assignment acknowledgement for a wireless communication system |
US8462859B2 (en) | 2005-06-01 | 2013-06-11 | Qualcomm Incorporated | Sphere decoding apparatus |
US8599945B2 (en) | 2005-06-16 | 2013-12-03 | Qualcomm Incorporated | Robust rank prediction for a MIMO system |
US9179319B2 (en) | 2005-06-16 | 2015-11-03 | Qualcomm Incorporated | Adaptive sectorization in cellular systems |
US8885628B2 (en) | 2005-08-08 | 2014-11-11 | Qualcomm Incorporated | Code division multiplexing in a single-carrier frequency division multiple access system |
US9209956B2 (en) | 2005-08-22 | 2015-12-08 | Qualcomm Incorporated | Segment sensitive scheduling |
US8644292B2 (en) | 2005-08-24 | 2014-02-04 | Qualcomm Incorporated | Varied transmission time intervals for wireless communication system |
US9136974B2 (en) | 2005-08-30 | 2015-09-15 | Qualcomm Incorporated | Precoding and SDMA support |
US9225416B2 (en) | 2005-10-27 | 2015-12-29 | Qualcomm Incorporated | Varied signaling channels for a reverse link in a wireless communication system |
US9088384B2 (en) | 2005-10-27 | 2015-07-21 | Qualcomm Incorporated | Pilot symbol transmission in wireless communication systems |
US9210651B2 (en) | 2005-10-27 | 2015-12-08 | Qualcomm Incorporated | Method and apparatus for bootstraping information in a communication system |
US8477684B2 (en) | 2005-10-27 | 2013-07-02 | Qualcomm Incorporated | Acknowledgement of control messages in a wireless communication system |
US9144060B2 (en) | 2005-10-27 | 2015-09-22 | Qualcomm Incorporated | Resource allocation for shared signaling channels |
US9225488B2 (en) | 2005-10-27 | 2015-12-29 | Qualcomm Incorporated | Shared signaling channel |
US8045512B2 (en) | 2005-10-27 | 2011-10-25 | Qualcomm Incorporated | Scalable frequency band operation in wireless communication systems |
US8582509B2 (en) | 2005-10-27 | 2013-11-12 | Qualcomm Incorporated | Scalable frequency band operation in wireless communication systems |
US8693405B2 (en) | 2005-10-27 | 2014-04-08 | Qualcomm Incorporated | SDMA resource management |
US20100255099A1 (en) * | 2007-10-26 | 2010-10-07 | Rexahn Pharmaceuticals, Inc. | Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US29038A (en) * | 1860-07-03 | George a | ||
NZ189022A (en) * | 1977-12-08 | 1981-11-19 | Beecham Group Ltd | Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder |
US5288861A (en) * | 1987-01-29 | 1994-02-22 | Beecham Group Plc | Potassium clavulanate in rosette form |
US5750685A (en) * | 1987-01-29 | 1998-05-12 | Smithkline Beecham, P.L.C. | Process for preparing potassium clavulanate in rossette form |
GB9109862D0 (en) * | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
AT403375B (en) * | 1995-11-15 | 1998-01-26 | Biochemie Gmbh | METHOD FOR FILLING ALKALINE SALTS OF CLAVULANIC ACID |
AT404728B (en) * | 1996-11-27 | 1999-02-25 | Biochemie Gmbh | METHOD FOR PRODUCING CLAVULIC ACID AMINE SALTS |
CA2364342C (en) * | 1999-04-01 | 2011-02-01 | Dsm N.V. | Agglomerates by crystallisation |
-
2001
- 2001-10-18 JP JP2002536287A patent/JP2004511561A/en active Pending
- 2001-10-18 EP EP01987751A patent/EP1328528B1/en not_active Expired - Lifetime
- 2001-10-18 US US10/399,427 patent/US20040043981A1/en not_active Abandoned
- 2001-10-18 PL PL01360254A patent/PL360254A1/en unknown
- 2001-10-18 MX MXPA03003312A patent/MXPA03003312A/en active IP Right Grant
- 2001-10-18 ES ES01987751T patent/ES2234919T3/en not_active Expired - Lifetime
- 2001-10-18 AT AT01987751T patent/ATE286057T1/en active
- 2001-10-18 DE DE60108154T patent/DE60108154T2/en not_active Expired - Lifetime
- 2001-10-18 CN CNB018175538A patent/CN1267437C/en not_active Expired - Lifetime
- 2001-10-18 CA CA2424462A patent/CA2424462C/en not_active Expired - Lifetime
- 2001-10-18 KR KR10-2003-7004308A patent/KR20030069995A/en active Search and Examination
- 2001-10-18 AU AU2002221702A patent/AU2002221702A1/en not_active Abandoned
- 2001-10-18 WO PCT/EP2001/012076 patent/WO2002032906A1/en active IP Right Grant
-
2009
- 2009-05-01 JP JP2009112262A patent/JP2009197020A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1328528A1 (en) | 2003-07-23 |
ATE286057T1 (en) | 2005-01-15 |
US20040043981A1 (en) | 2004-03-04 |
PL360254A1 (en) | 2004-09-06 |
EP1328528B1 (en) | 2004-12-29 |
CA2424462A1 (en) | 2002-04-25 |
CN1267437C (en) | 2006-08-02 |
ES2234919T3 (en) | 2005-07-01 |
CN1469880A (en) | 2004-01-21 |
JP2009197020A (en) | 2009-09-03 |
DE60108154T2 (en) | 2005-12-22 |
KR20030069995A (en) | 2003-08-27 |
JP2004511561A (en) | 2004-04-15 |
WO2002032906A1 (en) | 2002-04-25 |
MXPA03003312A (en) | 2004-12-03 |
CA2424462C (en) | 2010-03-30 |
DE60108154D1 (en) | 2005-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002221702A1 (en) | Pharmaceutical compositions | |
WO2001058412A3 (en) | Extracts from residues left in the production of wine | |
WO2001044271A3 (en) | Daptomycin analogs and their use as antibacterial agents | |
YU57600A (en) | Bicyclic hydroxamic acid derivatives | |
EP2295444A3 (en) | Lipopeptides as antibacterial agents | |
AU2001290257A1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
AU2001290257A2 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
WO2003054146A3 (en) | Self-assembly and mineralization of peptide-amphiphile nanofibers | |
WO2003024392A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2001272925A1 (en) | Use of interleukin-4 antagonists and compositions thereof | |
AU7620200A (en) | Compositions and methods relating to the inhibition of casomorphin and gluteomorphin | |
ZA948669B (en) | New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions | |
AU3227700A (en) | Skin sanitizing compositions | |
CA2361402A1 (en) | Bis-sulfonamides | |
CA2429639A1 (en) | Stable azithromycin monohydrate | |
AU2001289606A1 (en) | Dry powder formulation comprising racecadotril | |
WO2001045650A3 (en) | Cosmetic use of the residues from wine production | |
TNSN04034A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
AU7027100A (en) | Novel compounds | |
SE0001916D0 (en) | Novel formulation | |
AU4929400A (en) | Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof | |
AU2002341555A1 (en) | Levothyroxine pharmaceutical compositions, methods of making and methods of administration | |
AU2001279193A1 (en) | Methods and compositions for the construction and use of viral envelops as display particles | |
WO2001022917A3 (en) | Effervescent compositions comprising nimesulide | |
ATE259213T1 (en) | ORAL CLEANSER |